2-Pyrimidinamine, 5-(8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-(1,4)oxazino(4,3-e)purin-2-yl)-,
5-(6,6-Dimethyl-4-(4-morpholinyl)-8,9-dihydro-6H-(1,4)oxazino(4,3-e)purin-2-yl)-2-pyrimidinamine,
GDC-0084,
GDC-0084,
1382979-44-3,
GDC0084,
UNII-P5DKZ70636,
CHEMBL3813842,
P5DKZ70636,
5-(6,6-dimethyl-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyrimidin-2-amine,
2-Pyrimidinamine, 5-(8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-(1,4)oxazino(4,3-E)purin-2-yl)-,
2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-,
SCHEMBL10239943,
GTPL10097,
BCP18386,
EX-A1019,
GDC 0084,
BDBM50177662,
MFCD30187522,
RG7666,
s8163,
AKOS030526470,
ZINC149645112,
CS-5638,
GDC-0084 pound RG7666 pound(c),
SB19742,
compound 16 [PMID: 27096040],
AK547303,
HY-19962,
5-(6,6-Dimethyl-4-morpholino-8,9-dihydro-6H-[1,4]oxazino[4,3-e]purin-2-yl)pyrimidin-2-amine,
5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-2-pyrimidinamine,
LGWACEZVCMBSKW-UHFFFAOYSA-N,
A16272,